![]() |
市場調查報告書
商品編碼
1753953
2025 年至 2033 年腹膜透析市場報告(依治療類型(持續性門診腹膜透析、自動腹膜透析)、產品、最終用戶和地區)Peritoneal Dialysis Market Report by Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), Product, End User, and Region 2025-2033 |
2024年,全球腹膜透析市場規模達180億美元。展望未來, IMARC Group預計到2033年,市場規模將達到265億美元,2025-2033年期間的複合年成長率(CAGR)為4.16%。全球透析中心數量的不斷增加、政府推動腎臟疾病管理的舉措不斷增多、持續性非臥床腹膜透析(CAPD)的日益普及以及發展中國家醫療基礎設施的不斷擴大,共同推動著市場的發展。目前,受優惠的報銷政策和老齡人口不斷成長的推動,北美佔據著最大的腹膜透析市場佔有率。
腹膜透析 (PD) 是一種腎衰竭治療程序,透過手術將一根柔軟的塑膠管或導管置入腹腔內壁或腹部。置入後,無菌清潔液會經由導管輸送,幫助過濾體內血液,清除廢物。一段時間後,液體和過濾後的有害成分會從腹腔排出並被丟棄。 PD 分為持續性非臥床腹膜透析和持續性循環腹膜透析 (CCPD)。這些方法治療靈活,減少了前往透析中心的次數,並能獲得更好的臨床療效,從而減少藥物用量和飲食限制。此外,PD 可以在家中進行,無需針頭;因此,醫院和醫療中心經常使用 PD 來治療腎衰竭。
末期腎病(ESRD)盛行率不斷上升
末期腎病 (ESRD) 盛行率的不斷上升是推動全球腹膜透析市場成長的關鍵因素,因為 ESRD 患者需要透析或腎臟移植才能存活,而腹膜透析因其便利性和居家性質而成為首選治療方法。根據美國腎臟資料系統 (USRS) 的數據,2015 年新增 ESRD 診斷病例 124,411 例,且每年新增病例數約為 20,000 例。隨著全球 ESRD 病例數持續上升,對有效且便利的透析方案(包括腹膜透析)的需求也隨之成長。透析技術的進步進一步推動了這一趨勢,有助於滿足日益成長的 ESRD 人群日益成長的醫療保健需求。
糖尿病和高血壓發生率不斷上升
糖尿病和高血壓發生率的上升是推動腹膜透析市場佔有率擴大的重要因素,因為這些疾病是慢性腎病 (CKD) 和末期腎臟病 (ESRD) 的主要原因。糖尿病和高血壓都會損害血管並逐漸降低腎功能,最終需要透析或腎臟移植才能存活。隨著全球糖尿病和高血壓盛行率的上升,尤其是在老年人口中,腎衰竭病例也相應增加。因此,對包括腹膜透析在內的各種透析治療的需求正在增加,從而推動了腹膜透析市場的成長。這種透析為患者提供了一種方便的家庭解決方案,使其成為治療與這些常見健康狀況相關的腎衰竭的首選。
醫療支出不斷上漲
不斷成長的醫療保健支出也在推動市場發展,同時也使人們能夠更廣泛地獲得先進的透析治療。隨著全球(尤其是已開發國家)醫療保健支出的增加,越來越多的資金被分配用於管理腎衰竭等慢性疾病。這有利於改善基礎設施,培養訓練有素的醫療專業人員,並讓更多人獲得尖端的腹膜透析技術。此外,根據腹膜透析市場分析報告,醫療保健預算的增加促進了居家治療的普及,與中心血液透析相比,居家治療更具成本效益,也更加便利。全球許多國家的政府計畫和保險政策也更有利於支持長期透析護理,從而減輕了患者的經濟負擔,並推動了對作為綜合醫療保健體系一部分的、可及的高品質腹膜透析解決方案的需求。
The global peritoneal dialysis market size reached USD 18.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 26.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.16% during 2025-2033. The market is being driven by the rising number of dialysis centers worldwide, the increasing government initiatives to promote kidney disease management, the growing adoption of continuous ambulatory peritoneal dialysis (CAPD), and the expanding healthcare infrastructure in developing countries. At present, North America holds the largest peritoneal dialysis market share, driven by favorable reimbursement policies and the rising geriatric population.
Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual's body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.
Growing prevalence of end-stage renal disease (ESRD)
The growing prevalence of end-stage renal disease (ESRD) is a key factor driving the global peritoneal dialysis market growth as ESRD patients require dialysis or kidney transplantation to survive, with peritoneal dialysis emerging as a preferred treatment due to its convenience and home-based nature. According to the United States Renal Data System, there were 124,411 new ESRD diagnoses in 2015, with the disease increasing at about 20,000 cases per year. As the number of ESRD cases continues to rise globally, the demand for effective and accessible dialysis options, including peritoneal dialysis, increases. This trend is further supported by advancements in dialysis technologies, helping to meet the growing healthcare needs of the expanding ESRD population.
Increasing incidences of diabetes and hypertension
The rising incidences of diabetes and hypertension are significant drivers contributing to the augmenting peritoneal dialysis market share, as these conditions are the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Both diabetes and hypertension damage blood vessels and reduce kidney function over time, ultimately requiring dialysis or kidney transplantation for survival. With the global prevalence of diabetes and hypertension on the rise, particularly in aging population, there has been a corresponding increase in kidney failure cases. As a result, the demand for various dialysis treatments, including peritoneal dialysis, is escalating, thereby impelling the peritoneal dialysis market growth. This type of dialysis offers a convenient, home-based solution for patients, making it a preferred choice for managing kidney failure linked to these common health conditions.
Rising healthcare expenditures
Rising healthcare expenditures are also driving the market while enabling broader access to advanced dialysis treatments. As healthcare spending increases globally, especially in developed countries, more funds are allocated to managing chronic diseases like kidney failure. This allows for improved infrastructure, better-trained medical professionals, and access to cutting-edge peritoneal dialysis technologies. Additionally, according to the peritoneal dialysis market analysis report, increased healthcare budgets facilitate the adoption of home-based treatments, which can be more cost-effective and convenient compared to in-center hemodialysis. Government programs and insurance policies are also better positioned across numerous countries across the globe to support long-term dialysis care, thus easing the financial burden on patients and driving the demand for accessible, quality peritoneal dialysis solutions as part of comprehensive healthcare systems.